Pfizer Takes Aim At Moderna's Leftover MRNA Protections
Law360, London: Pfizer asked an appeals court on 10 July 2025 to revoke surplus patent protections underpinning rival Moderna's mRNA vaccine after getting a key patent tossed.
The law of confidentiality is often the best way of protecting trade secrets and valuable know-how where these are not otherwise adequately protected by other means (eg via intellectual property rights), or where using other types of protection is unattractive for commercial reasons.
Even if other types of rights exist (eg patent rights in the case of patented inventions), often the real value of an invention or new piece of technology does not lie just in the invention itself, but also in the associated know-how, training and guidance required to fully exploit it. Therefore, the law of confidentiality also helps to protect valuable information associated with (for instance) an invention, along with financial, customer and similar confidential information that a business holds.
Examples of items which might be considered confidential within a business include:
To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.